Latigo Biotherapeutics, Inc. (LTGO) KPIs and segments
LTGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026
$13.76+1.16 (+9.21%)
Close on Nov 17, 2026Market cap $912.28MP/E –Yield 0.00%
KPIs & segments
Operating metrics and segments that drive Latigo Biotherapeutics's business
Coming soon
This tab will track the numbers specific to Latigo Biotherapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?